James Healy's Net Worth

$1.57 Billion

Estimate Recalculated Feb 23, 2024 09:42PM EST

Who is James Healy?

James Healy has an estimated net worth of $1.57 Billion. This is based on reported shares across multiple companies, which include Natera, Inc., ArriVent Biopharma, Inc., CinCor Pharma, Inc., AMARIN CORP PLC\UK, COTHERIX INC, Trius Therapeutics Inc, HYPERION THERAPEUTICS INC, Y-mAbs Therapeutics, Inc., MARINUS PHARMACEUTICALS INC, HISTOGENICS CORP, Vera Therapeutics, Inc., Aclaris Therapeutics, Inc., Karuna Therapeutics, Inc., Aerovate Therapeutics, Inc., AERIE PHARMACEUTICALS INC, Coherus BioSciences, Inc., Edge Therapeutics, Inc., Inozyme Pharma, Inc., KALOBIOS PHARMACEUTICALS INC, Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Checkmate Pharmaceuticals, Inc., Galera Therapeutics, Inc., Bolt Biotherapeutics, Inc., Principia Biopharma Inc., NextCure, Inc., Mirna Therapeutics, Inc., THRESHOLD PHARMACEUTICALS INC, aTYR PHARMA INC, ALIMERA SCIENCES INC, Akouos, Inc., NOVACEA INC, Durata Therapeutics, Inc., Versartis, Inc., Anthera Pharmaceuticals Inc, Spark Therapeutics, Inc., Ocera Therapeutics, Inc., ANESIVA, INC., and INTERMUNE INC.

SEC CIK

James Healy's CIK is 0001245624

Past Insider Trading and Trends

2013 was James Healy's most active year for acquiring shares with 36 total transactions. James Healy's most active month to acquire stocks was the month of April. 2014 was James Healy's most active year for disposing of shares, totalling 50 transactions. James Healy's most active month to dispose stocks was the month of April. 2022 saw James Healy paying a total of $40,073,456.41 for 6,666,686 shares, this is the most they've acquired in one year. In 2015 James Healy cashed out on 30,080,297 shares for a total of $90,430,066.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Natera, Inc. (NTRA) Snapshot price: $70.245

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.63%
264
$63.79
$16,840.56
42.5K
Jan 26
Form 4
-100.00%
-644.00K
$58.75
-$37,835,000.00
0
Dec 13
Form 4
+0.95%
396
$42.60
$16,869.60
42.24K
Oct 27
Form 4
+0.79%
328
$48.48
$15,901.44
41.84K
Jul 28
Form 4
+7.09%
2.75K
41.51K
Jun 30
Form 4
+10.03%
3.53K
38.76K
May 25
Form 4
+0.82%
285
$54.73
$15,598.05
35.23K
Apr 14
Form 4
+1.13%
390
$40.01
$15,603.90
34.94K
Jan 13
Form 4
-100.00%
-2.40K
$37.71
-$90,498.00
0
Nov 16
Form 4
+1.01%
344
$45.42
$15,624.48
34.55K
Oct 14
Form 4/A
+1.27%
430
34.21K
Jul 8
Form 4
0
0
Jul 8
Form 4
0
0
May 27
Form 4
+4.03%
1.31K
33.78K
May 25
Form 4
2.4K
$113.00
$271,200.00
2.4K
Jul 22
Form 4
+9.64%
2.86K
32.47K
May 28
Form 4
0
0
Jun 12
Form 4
+306.92%
22.34K
$11.11
$248,063.49
29.62K
Jan 10
Form 4
7.28K
7.28K
May 16
Form 4
0
0
May 24
Form 4
0
0
Apr 12
Form 4/A
0
0
Sep 14
Form 4
0
0
Sep 14
Form 4
0
0
Jun 9
Form 4
0
0
Jun 10
Form 4
+675.14%
2.7M
$18.00
3.1M
Jul 8
Form 4
400K
$22.81
$9,123,800.00
400K
Jul 2
Form 3
0
0
No matching records found

ArriVent Biopharma, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.7M
$18.00
1.7M
Jan 30
Form 3
0
0
No matching records found

No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.11M
$14.32
-$85,920.00
0
Nov 28 - Feb 24
Form 4
+9.08%
506K
$30.00
$15,180,000.00
6.08M
Aug 11
Form 4
29.41K
$13.60
$399,989.60
29.41K
Aug 5
Form 4
5.57M
$16.00
5.57M
Jan 11
Form 3
0
0
No matching records found

AMARIN CORP PLC\UK (AMRN) Snapshot price: $1.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jul 11
Form 4
0
0
Jul 10
Form 4
0
0
Jul 6
Form 4
0
0
Mar 11
Form 4
0
0
Jul 9
Form 4
+50.00%
30K
$1.03
$30,900.00
90K
Aug 31
Form 4
+14.66%
808.2K
$1.50
$1,212,300.00
6.32M
Aug 14
Form 4
0
0
Jul 10
Form 4
0
0
Apr 4
Form 4
-26.62%
-2.00M
$10.98
-$21,964,950.45
5.51M
Apr 2 - Apr 3
Form 4
-11.75%
-1.00M
$10.98
-$10,984,726.50
7.51M
Mar 28 - Mar 29
Form 4
60K
$1.03
$61,800.00
60K
Jan 27
Form 4
-4.75%
-424.90K
$7.25
-$3,080,609.98
8.51M
Mar 29
Form 4
-6.05%
-575.10K
$7.55
-$4,341,332.61
8.94M
Mar 24 - Mar 25
Form 4
-17.37%
-2.00M
$7.50
-$15,000,000.00
9.51M
Mar 11
Form 4
-5.24%
-637.00K
$7.26
-$4,622,857.88
11.51M
Mar 9 - Mar 10
Form 4
-2.90%
-363.00K
$8.13
-$2,952,787.20
12.15M
Feb 25
Form 3
0
0
No matching records found

COTHERIX INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.40M
$13.50
-$32,339,236.50
0
Jan 9
Form 4
0
0
Jan 3
Form 4
0
0
Jan 3
Form 4
0
0
Jan 3
Form 4
+372.06%
1.86M
2.36M
Oct 20
Form 4
+252.10%
358.43K
$6.00
$2,150,556.00
500.6K
Oct 15
Form 3
0
0
No matching records found